Wilmington Savings Fund Society’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,000
| Closed | -$63K | – | 362 |
|
|
2022
Q4 | $63K | Hold |
10,000
| – | – | ﹤0.01% | 351 |
|
|
2022
Q3 | $51K | Hold |
10,000
| – | – | ﹤0.01% | 351 |
|
|
2022
Q2 | $63K | Hold |
10,000
| – | – | ﹤0.01% | 360 |
|
|
2022
Q1 | $36K | Hold |
10,000
| – | – | ﹤0.01% | 373 |
|
|
2021
Q4 | $50K | Hold |
10,000
| – | – | ﹤0.01% | 386 |
|
|
2021
Q3 | $73K | Hold |
10,000
| – | – | ﹤0.01% | 388 |
|
|
2021
Q2 | $86K | Hold |
10,000
| – | – | ﹤0.01% | 390 |
|
|
2021
Q1 | $108K | Buy |
+10,000
| New | +$97.1K | ﹤0.01% | 369 |
|
|
2018
Q2 | – | Sell |
-3,500
| Closed | -$215K | – | 372 |
|
|
2018
Q1 | $215K | Hold |
3,500
| – | – | 0.01% | 321 |
|
|
2017
Q4 | $188K | Hold |
3,500
| – | – | 0.01% | 335 |
|
|
2017
Q3 | $236K | Hold |
3,500
| – | – | 0.01% | 312 |
|
|
2017
Q2 | $190K | Hold |
3,500
| – | – | 0.01% | 330 |
|
|
2017
Q1 | $125K | Hold |
3,500
| – | – | 0.01% | 329 |
|
|
2016
Q4 | $112K | Buy |
+3,500
| New | +$128K | 0.01% | 322 |
|
Wilmington Savings Fund Society's FSTX Position: Q1 2023 in Review
Wilmington Savings Fund Society sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 10,000 shares — an estimated $63K sold.
Wilmington Savings Fund Society first reported a position in FSTX in Q4 2016 and held it in 14 quarters. The position peaked at $236K in Q3 2017. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Wilmington Savings Fund Society reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Wilmington Savings Fund Society sold 10,000 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $63K.
- Wilmington Savings Fund Society first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2016 and held it in 14 quarters.
- Wilmington Savings Fund Society's F-star Therapeutics, Inc. Common Stock position peaked at $236K in Q3 2017.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on Wilmington Savings Fund Society's 13F filing for Q1 2023, filed 15 May 2023.